Who owns the NIKANG THERAPEUTICS trademark?

The NIKANG THERAPEUTICS trademark is owned by NiKang Therapeutics, Inc..

What class is the NIKANG THERAPEUTICS trademark registered in?

The NIKANG THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for NIKANG THERAPEUTICS?

The USPTO serial number for NIKANG THERAPEUTICS is 97284685.

What is the registration number for NIKANG THERAPEUTICS?

NIKANG THERAPEUTICS is registered under USPTO registration number 7295322.

NIK

USPTO Trademark Record

REGISTERED

NIKANG THERAPEUTICS

SN 97284685·Reg 7295322·Filed Feb 25, 2022

Owner NiKang Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

NIKANG THERAPEUTICS (Serial No. 97284685), Registration No. 7295322, is a registered US trademark filed on Feb 25, 2022 by NiKang Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: January 30, 2030

Mark Intelligence

NIKANG THERAPEUTICS (Reg. #7295322) is a registered US trademark that has been protecting its owner, NiKang Therapeutics, Inc., since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 25, 2022

SERIAL

97284685

REG#

7295322

REGISTERED

Jan 30, 2024

Owner

Applicant

NiKang Therapeutics, Inc.

Entity

Corporation

State

Address

200 Powder Mill Road, Bldg E500, Wilmington, DE, 19803

Country

Attorney

NamePhilip R. Zender

Law firm

Philip R. Zender SQUIRE PATTON BOGGS (US) LLP

Docket

119005.00137

Address

555 California Street, Suite 550, SAN FRANCISCO, CA 94104, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 25, 2022

Serial Number97284685

Registration No.7295322

Registration DateJan 30, 2024

Status DateJan 30, 2024

Published for OppositionApr 18, 2023

Mark TypeStandard characters

Attorney Docket119005.00137

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Oct 31, 2023

First use in commerce: Oct 31, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

22 events

REGISTERED-PRINCIPAL REGISTER

Jan 30, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 30, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Dec 26, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Dec 25, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 10, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Dec 10, 2023

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Nov 30, 2023

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Nov 30, 2023

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 13, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 18, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 18, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 29, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 10, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 08, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 07, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 07, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO EXAMINER

Dec 09, 2022

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Dec 09, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 09, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 09, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 02, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 01, 2022

NEW APPLICATION ENTERED

NIKANG THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by NiKang Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Philip R. Zender

Resources

Company